Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Aug 27, 2014 tessier-lavigne marc Director Option Execute 3,000 50.91
May 6, 2013 tessier-lavigne marc Director Option Execute 13,334 50.91 - 57.11
Sep 18, 2013 vagelos p roy Officer Option Execute 312,500 13.00
Nov 23, 2012 vagelos p roy Officer Option Execute 312,500 19.43
Aug 26, 2014 vagelos p roy Officer Option Execute 303,909 11.64
Aug 7, 2014 vagelos p roy Officer Option Execute 270,352 9.49
Feb 27, 2014 vagelos p roy Officer Option Execute 70,879 9.49 - 21.92
Dec 8, 2009 vagelos p roy Director Option Execute 187,500 8.77
Dec 19, 2008 vagelos p roy Director Option Execute 130,000 7.41
Aug 31, 2011 vagelos p roy Officer Option Execute 312,500 28.01
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Aug 4, 2011 van plew daniel p Officer Option Execute 4,784 20.90
Apr 27, 2012 van plew daniel p Officer Option Execute 35,216 20.90
Jan 18, 2011 van plew daniel p Officer Option Execute 25,000 20.90 - 21.92
Dec 16, 2010 van plew daniel p Officer Option Execute 25,000 20.90
Aug 6, 2014 van plew daniel p Officer Option Execute 15,000 21.25
May 22, 2014 van plew daniel p Officer Option Execute 11,200 21.25
Nov 12, 2014 van plew daniel p Officer Option Execute 18,700 21.25
Aug 5, 2015 van plew daniel p Officer Option Execute 8,700 21.25 - 30.63
May 22, 2015 van plew daniel p Officer Option Execute 40,050 21.25 - 30.63
Showing 401-420 of 1029 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)